ResearcherSoochow UniversityNo recent work listed

Ying Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3563-4233; OpenAlex author ID A5074969305. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

Disulfiram Alone Functions as a Radiosensitizer for Pancreatic Cancer Both In Vitro and In Vivo. Co-author DOI 10.3389/fonc.2021.683695 ↗
Luminescent ruthenium(II) polypyridyl complexes acted as radiosensitizer for pancreatic cancer by enhancing radiation-induced DNA damage. First author DOI 10.7150/thno.34015 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yang Jiao · 2 shared papers, 2019–2021 · strength 0.25
- Paper Disulfiram Alone Functions as a Radiosensitizer for Pancreatic Cancer Both In Vitro and In Vivo. DOI 10.3389/fonc.2021.683695 ↗
- Paper Luminescent ruthenium(II) polypyridyl complexes acted as radiosensitizer for pancreatic cancer by enhancing radiation-i… DOI 10.7150/thno.34015 ↗
Qi Zhang · 2 shared papers, 2019–2021 · strength 0.25
- Paper Disulfiram Alone Functions as a Radiosensitizer for Pancreatic Cancer Both In Vitro and In Vivo. DOI 10.3389/fonc.2021.683695 ↗
- Paper Luminescent ruthenium(II) polypyridyl complexes acted as radiosensitizer for pancreatic cancer by enhancing radiation-i… DOI 10.7150/thno.34015 ↗
Jianping Cao · 2 shared papers, 2019–2021 · strength 0.25
- Paper Disulfiram Alone Functions as a Radiosensitizer for Pancreatic Cancer Both In Vitro and In Vivo. DOI 10.3389/fonc.2021.683695 ↗
- Paper Luminescent ruthenium(II) polypyridyl complexes acted as radiosensitizer for pancreatic cancer by enhancing radiation-i… DOI 10.7150/thno.34015 ↗
Yuyang Zhou · 1 shared paper, 2019 · strength 0.10
- Paper Luminescent ruthenium(II) polypyridyl complexes acted as radiosensitizer for pancreatic cancer by enhancing radiation-i… DOI 10.7150/thno.34015 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.